Developing chemoresistance to tyrosine kinase inhibitors

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F19%3A43917144" target="_blank" >RIV/62156489:43210/19:43917144 - isvavai.cz</a>
Result on the web
<a href="https://mnet.mendelu.cz/mendelnet2019/mnet_2019_full.pdf" target="_blank" >https://mnet.mendelu.cz/mendelnet2019/mnet_2019_full.pdf</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Developing chemoresistance to tyrosine kinase inhibitors
Original language description
Resistance to tyrosine kinase inhibitors (TKIs) is a major issue in cancer therapy, as almost every patient undergoing this treatment gains chemoresistance. In this project, we attempted to develop chemoresistant cell lines insensitive to three recently approved TKIs - vandetanib, lenvatinib and cabozantinib. Our goal was to obtain these cell lines by continuous growth in the presence of said inhibitors for further examination and research of chemoresistance mechanisms. Unfortunately, we came across some problems and the long-term character of our experiment forced us to take up a different approach. In the future, we plan to continue our project by inducing chemoresistance with transfection of an expression vector containing mutated sequence of receptor tyrosine kinase.
Czech name
—
Czech description
—

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Article name in the collection
MendelNet 2019: Proceedings of International PhD Students Conference
ISBN
978-80-7509-688-3
ISSN
—
e-ISSN
—
Number of pages
4
Pages from-to
632-635
Publisher name
Mendelova univerzita v Brně
Place of publication
Brno
Event location
Brno
Event date
Nov 6, 2019
Type of event by nationality
WRD - Celosvětová akce
UT code for WoS article
000576735500114

Similar results(10)